VATE Stock Forecast 2025-2026
Distance to VATE Price Targets
VATE Price Momentum
10 Quality Stocks Worth Considering Now
Researching Elev8 Brands (VATE) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on VATE and similar high-potential opportunities.
Latest VATE Stock Price Targets & Analyst Predictions
VATE has shown a year-to-date change of 72.9% and a 1-year change of 31.4%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for VATE. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VATE Analyst Ratings
VATE Price Target Range
Latest VATE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VATE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Innovate Corp. (VATE) Competitors
The following stocks are similar to Elev8 Brands based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Innovate Corp. (VATE) Financial Data
Innovate Corp. has a market capitalization of $116.97M with a P/E ratio of -1.7x. The company generates $1.23B in trailing twelve-month revenue with a -2.2% profit margin.
Revenue growth is -35.5% quarter-over-quarter, while maintaining an operating margin of +2.4% and return on equity of +24.8%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Innovate Corp. (VATE) Business Model
About Innovate Corp.
Diversified holding company in industrial and financial services.
The company acquires and manages a portfolio of subsidiary companies across industrial and financial sectors, generating revenue through operational efficiencies and strategic growth opportunities. It operates in engineering, construction, and maintenance, while also providing insurance and asset management services to both businesses and individuals.
Innovate Corp. focuses on creating synergies between its diverse operations and leverages industry expertise to enhance value creation. By pursuing strategic acquisitions and innovative management practices, the company aims to capitalize on emerging market trends and maintain its influential position in the market.
Company Information
Sector
Industrials
Industry
Engineering & Construction
Employees
3,946
CEO
Country
United States
IPO Year
2021
Website
www.innovatecorp.comInnovate Corp. (VATE) Latest News & Analysis
INNOVATE Corp. (NYSE: VATE) will release its Q4 and full-year 2024 financial results on March 31, 2025, after market close, followed by a conference call at 4:30 p.m. ET.
The upcoming earnings release and conference call on March 31, 2025, will provide insights into INNOVATE Corp.'s financial performance and strategic direction, influencing investor expectations and stock price.
The TGFR system offers a novel point-of-care method for assessing kidney function. Recent MediBeacon study results compare mGFR with eGFR for CKD classification, published in the Clinical Kidney Journal.
The TGFR system's innovative approach to kidney function assessment could disrupt renal diagnostics, potentially increasing market share for MediBeacon and impacting stock valuation.
INNOVATE Corp. (NYSE: VATE) announced FDA approval for its MediBeacon® TGFR, which assesses kidney function in patients with normal or impaired renal function.
FDA approval of MediBeacon® TGFR enhances INNOVATE's product portfolio, potentially increasing revenue and market share in the healthcare sector, which can positively impact stock performance.
R2 Technologies, Inc., a leader in CryoAesthetics® and part of INNOVATE Corp. (NYSE: VATE), announced significant milestones in 2024, enhancing growth prospects in the aesthetics and wellness industries.
R2 Technologies' milestones and partnerships signal potential revenue growth, enhancing INNOVATE Corp.'s market position and attractiveness to investors in the aesthetics sector.
INNOVATE Corp. (VATE) held its Q3 2024 earnings call, discussing financial performance and future outlook. Further details on earnings and strategic initiatives were shared during the call.
The Q3 2024 earnings call for INNOVATE Corp. (VATE) provides insights into financial performance, trends, and future guidance, influencing stock valuation and investment decisions.
INNOVATE Corp. Announces Third Quarter 2024 Results
4 months agoDBM Global reported Q3 revenue of $232.8 million. R2 achieved record unit sales growth in Life Sciences, while Spectrum continued strong growth from network launches.
DBM Global's revenue growth signals strong demand in infrastructure. R2's record sales in life sciences and Spectrum's growth indicate robust performance across sectors, suggesting positive market trends.
Frequently Asked Questions About VATE Stock
What is Innovate Corp.'s (VATE) stock forecast for 2025?
Analyst forecasts for Innovate Corp. (VATE) are not currently available. The stock is trading at $8.54.
Is VATE stock a good investment in 2025?
Analyst ratings for VATE are not currently available. The stock is currently trading at $8.54. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VATE stock?
Price predictions from Wall Street analysts for VATE are not currently available. The stock is trading at $8.54.
What is Innovate Corp.'s business model?
The company acquires and manages a portfolio of subsidiary companies across industrial and financial sectors, generating revenue through operational efficiencies and strategic growth opportunities. It operates in engineering, construction, and maintenance, while also providing insurance and asset management services to both businesses and individuals.
What is the highest forecasted price for VATE Innovate Corp.?
Price targets from Wall Street analysts for VATE are not currently available. The stock is trading at $8.54.
What is the lowest forecasted price for VATE Innovate Corp.?
Price targets from Wall Street analysts for VATE are not currently available. The stock is trading at $8.54.
What is the overall VATE consensus from analysts for Innovate Corp.?
Analyst ratings for VATE are not currently available. The stock is trading at $8.54.
How accurate are VATE stock price projections?
Stock price projections, including those for Innovate Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
